Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02953782 |
Title | Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Forty Seven, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCLA | Los Angeles | California | 90404 | United States | Details | |
Stanford University | Palo Alto | California | 94305-5757 | United States | Details | |
Wayne State University | Detroit | Michigan | 48201 | United States | Details | |
START Midwest | Grand Rapids | Michigan | 49503 | United States | Details | |
UPENN | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
Md Anderson | Houston | Texas | 77030 | United States | Details | |
START Center for Cancer Care | San Antonio | Texas | 78229 | United States | Details |